Abstract
Gonadotropin-releasing hormone agonists in an alternate-day dosage resulted in similar clinical pregnancy rates as the daily protocol. No premature luteinization was reported in either group. Total GnRH agonist dosage in the alternate-day protocol was significantly reduced.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Drug Administration Schedule
-
Female
-
Fertilization
-
Health Care Costs*
-
Humans
-
Infertility, Female / drug therapy*
-
Oocytes
-
Ovulation Induction / economics*
-
Ovulation Induction / methods*
-
Pregnancy
-
Pregnancy Rate
-
Sperm Injections, Intracytoplasmic
-
Tissue and Organ Harvesting
-
Triptorelin Pamoate / administration & dosage*
-
Triptorelin Pamoate / therapeutic use